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SUMMARY
1. Intracellular recordings were obtained from neurones in layers 2 and 3 of
the rat frontal neocortex in an in vitro slice preparation. Three distinct types of
stimulation-evoked post-synaptic potentials were recorded in these neurones: ex-
citatory post-synaptic potentials (e.p.s.p.s); bicuculline-sensitive, chloride-dependent
inhibitory post-synaptic potentials (i.p.s.p.s) with times to peak of 20-25 ms (fast(f)-
i.p.s.p.s); bicuculline-insensitive, potassium-dependent i.p.s.p.s with times to peak of
150-250 ms (long(l)-i.p.s.p.s).
2. The effects of baclofen were investigated on seventy-one neurones. Baclofen was
applied by ionophoresis or pressure ejection from micropipettes or was added to the
superfusion medium.
3. Baclofen depressed stimulation-evoked e.p.s.p.s in fifty-seven of the sixty
neurones tested. This effect was associated with an intcrease in the stimulation
intensity required to produce a synaptically evoked action potential for thirty-nine
of forty-four neurones.
4. Baclofen depressed f-i.p.s.p.s in thirty-seven of the thirty-nine neurones tested
and l-i.p.s.p.s in each one of the seventeen neurones tested. Reversal potential values
for each type of i.p.s.p. were not changed by baclofen and its depressions ofeach were
independent of membrane potential (Em). Baclofen reduced the magnitude and the
duration of the conductance increases that were associated with f- and l-i.p.s.p.s.
5. Baclofen hyperpolarized forty of seventy-one neurones and produced outward
currents in three of four neurones recorded in voltage clamp at holding potentials
between -55 and -65 mV. These actions were associated with 10-58% reductions
of neuronal input resistance (RN) and 10-20 % increases in neuronal input conduct-
ance (9N), respectively. Baclofen decreased the direct excitability of twenty-three of
twenty-seven neurones tested. Determinations of the reversal potential for baclofen-
induced changes of Em indicate that baclofen increases the conductance of rat
neocortical neurones to potassium ions.
6. The EC50 for each action of DL-baclofen was approximately 1 g1M. L-Baclofen
was > 100 times more potent than D-baclofen.
7. Concentrations of bicuculline that blocked f-i.p.s.p.s and responses to iono-
phoretically applied y-aminobutyric acid (GABA) had no effect on the depressions of
e.p.s.p.s or the hyperpolarizations and decreases in RN that baclofen produced.
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8. Baclofen did not reduce the duration of action potentials that were prolonged
with intracellular injections of caesium ions or by superfusions with medium that
contained 10 mM-tetraethylammonium (TEA).
9. Almost complete depressions of post-synaptic potentials were observed for some
neurones on which baclofen produced no hyperpolarization or apparent decrease in
RN. Baclofen's depressions of post-synaptic potentials outlasted the hyperpolariza-
tions and the decreases in RN and direct excitability that baclofen produced, often
by several minutes. Applications of baclofen that produced almost complete de-
pressions of post-synaptic potentials did not significantly reduce depolarizations
produced by L-glutamate, L-aspartate, N-methyl-D-aspartate (NMDA), or GABA.
At the same time that baclofen decreased resting RN, conductance increases during
stimulation-evoked i.p.s.p.s were reduced by baclofen. These results indicate that
baclofen depresses post-synaptic potentials evoked in rat neocortical neurones by an
action that is additional to and separate from its action to increase post-synaptic
potassium conductance.
INTRODUCTION
In 1973, Pierau & Zimmermann reported that the GABA analogue baclofen
(/3-chlorophenyl-GABA) depressed e.p.s.p.s evoked in cat motoneurones at doses
that had no effect on i.p.s.p.s or on the passive electrical properties or direct
excitability of these cells. They concluded that baclofen acted presynaptically to
inhibit central excitatory neurotransmission, and subsequent electrophysiological
studies supported this conclusion (Davidoff & Sears, 1974; Fox, Krnjevic, Morris,
Puil & Werman, 1978; Lanthorn & Cotman, 1981; Ault & Nadler, 1982; Olpe,
Baudry, Fagni & Lynch, 1982). There have also been reports, however, that baclofen
depresses i.p.s.p.s (Fox et al. 1978; Misgeld, Klee & Z4eise, 1982; Scholfield, 1983) and
has a direct hyperpolarizing action on some mammalian central neurones (Misgeld
et al. 1982; Newberry & Nicoll, 1984; Brady & Swann, 1984). This hyperpolarizing
action has been shown to be secondary to an increase in a voltage-dependent
potassium conductance (Gaihwiler & Brown, 1985; Inoue, Matsuo & Ogata, 1985a;
Newberry & Nicoll, 1985).
It is now established that there are two classes of GABA receptor, GABAA and
GABAB, and that baclofen is a protypical agonist at GABAB receptors (Bowery, Hill,
Hudson, Doble, Middlemiss, Shaw & Turnball, 1980; Hill & Bowery, 1981). Because
ofthe high density ofGABAB receptor binding sites in the mammalian cerebral cortex
(Karbon, Duman & Enna, 1983; Gehlert, Yamamura & Wamsley, 1985) and the
multiple actions of baclofen observed in previous electrophysiological studies, we
undertook to determine the effects of baclofen on rat neocortical neurones in an
in vitro slice preparation. Some of the results were published previously in abstract
form (Howe, Sutor & Zieglgiinsberger, 1985; Sutor, Howe & Zieglgainsberger, 1985).
METHODS
Adult Sprague-Dawley rats (120-160 g) were anaesthetized with ether and decapitated. Their
brains were removed rapidly, placed in oxygenated superfusion medium (4 0), and sectioned with
a razor blade such that transverse slices ofeach cerebral hemisphere could be cut in a plane ofsection
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perpendicular to the dorsal surface of the frontal cerebral cortex. Eight serial slices (nominally
500 ,um thick) were cut from the frontal poles of each hemisphere with a Mcllwain Tissue Chopper.
After incubation at ambient room temperature for at least 1 h, slices (commonly those from the
centre of each set) were placed in a continuous superfusion chamber and the temperature of the
superfusion medium in this chamber was slowly heated to and maintained at 36-37 'C. The slices
lay on a net and were superfused from below. Warm humidified air was circulated over the chamber
to prevent the upper surfaces of the slices from drying.
The standard superfusion medium had the following composition (in mM): NaCl, 122-75; KCl,
5-00; NaH2PO4, 1-25; CaCl2, 2-50; MgSO4, 1P30; NaHCO3, 26; glucose, 10. The superfusion medium
was gassed continuously with 95 % 02-5% CO2 and had a final pH of 7-4. When the concentration
of KCI in the standard medium was reduced, this was compensated for with equimolar NaCl. The
medium in which TEA was applied contained (in mM): NaCl, 1 1765; KCl, 2-50; CaCl2, 2-50; MgCl,
1P30; NaHCO3; 26; glucose, 10; TEA Cl, 10.
Solutions for superfusion were changed by switching a 4-way valve. The volume of the inflow
system from this valve to the chamber was 0-8 ml and the chamber volume was 10 ml. Solutions
were superfused at rates of 3 5-5 ml/min. The minimum time for replacement of the chamber
volume with a new solution was therefore 20-30 s. With this superfusion system, responses to
changes in the ionic composition of the medium required 5-10 min to reach steady state. All
solutions were pre-warmed and equilibrated with 95% 02-5% CO2.
Intracellular recordings were obtained from neurones in cortical layers 2 or 3 of the dorsomedial
region of the slices with glass micro-electrodes that were filled with either potassium acetate
(4 M, pH adjusted to 7 0 with acetic acid), potassium methylsulphate (KMeSO4, 2 M), or 1 M-CsCl.
Electrodes typically had resistances of50-80 MCI. Post-synaptic potentials were evoked by electrical
stimulation (0 05 ms in duration) of superficial cortical layers with a bipolar silver stimulation
electrode that was insulated to within 250 #m of the electrode tips (tip diameter: 100 /sm; separation
of tips: 250 psm). The stimulation electrode was positioned such that a line drawn between the tips
would be approximately perpendicular to the dorsal surface of the cortex and so that the most dorsal
tip of the bipolar electrode was 100-150 ,um from this surface. The stimulation electrode was placed
0-8-15 mm from the medial border of the slice and the tips were advanced into the slice 200-250 ,um.
All recordings were obtained medial to and 04-10 mm away from the stimulation electrode.
Conventional display techniques were used and signals were stored on magnetic tape (frequency
response of tape recorder: 1P25 kHz). In some cases, the replayed signals were digitized and analysed
with an LSI 11/73 computer.
Intracellular recordings and current injections were performed with a Dagan 8100 amplifier that
was equipped with a bridge circuit and also with sample and hold single-electrode current-clamp
and voltage-clamp modes (Wilson & Goldner, 1975; switching frequency set between 1 and 2 kHz,
25% duty cycle). Some voltage-clamp recordings were made with a npi SECIL (Fa. Polder, F.R.G.)
single-electrode voltage-clamp amplifier (switching frequency, 10-12 kHz; duty cycle, 25%).
Determinations of RN, neuronal input resistance, were made with 150 ms rectangular-current
injections that produced hyperpolarizing voltage transients of < 10 mV or from the slope of
current-voltage relation plots. When recordings were made in voltage clamp, neuronal input
conductance, 9N, was estimated from the steady-state current responses to 150 ms, 10 mV
hyperpolarizing voltage command steps. Membrane potential values were corrected for offset
potentials that were determined by rapidly withdrawing the electrode at the end of the recording.
Baclofen was applied at known concentration in the superfusion medium or from micropipettes
by ionophoresis or pressure ejection with a Neuro Phore BH2 unit. Unless it is stated otherwise,
the racemic mixture was applied. Bicuculline methiodide was applied in the superfusion medium.
L-glutamate, L-aspartate, N-methyl-D-aspartate (NMDA), and GABA were applied from micro-
pipettes by ionophoresis. The 4-barrelled micropipettes (total tip broken to 3-5 ,um) for ionophoresis
or pressure ejection were positioned under microscopic control as close to the recording electrode
as possible with an independent micromanipulator, advanced into the slice, and positioned to
obtain maximal responses to ionophoretic ejections of L-glutamate and GABA. Solutions for
ionophoresis were: NaCl, 1 M; baclofen, 10 mm, pH 40; GABA, 0-5 M; pH 4-5; sodium L-glutamate
or sodium L-aspartate, 1 M, pH 8-0; NMDA, 25 mM; pH 8-0. Baclofen and GABA were ejected with
cationic currents and L-glutamate, L-aspartate, and NMDA were ejected with anionic currents.
Retaining currents (5-10 nA) were applied when the substances were not ejected actively.
Automatic current neutralization was employed at all times.
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In most cases, the range and mean+ S.D. of the measured values are reported. In cases where
the sample size is small or the sample values were not normally distributed, the median value is
reported. Two-tailed Student's t tests were used for comparisons of two sample means. Quoted n
values refer to the number of neurones for which the result was demonstrated. The reversibility
of baclofen's effects is stated as full or partial, respectively, when the measured parameter recovered
to within 75-100% or 50-75% of its value before baclofen.
RESULTS
Characteristics of rat neocortical neurones
Stable intracellular recordings of 1-6 h in duration were obtained from seventy-one
neurones upon which baclofen was applied by ionophoresis (n = 15) or pressure
ejection (n = 4) from micropipettes or by addition to the superfusion medium
(n = 52). Some of the characteristics of these neurones and of their responses to
current injections or to electrical stimulation of superficial cortical layers are
summarized in Table 1. The current-voltage relations determined for these neurones
were always non-linear and exhibited depolarizing and hyperpolarizing inward
rectification. The dependence of RN on the membrane potential, Em, was further
investigated in nineteen neurones by applying 150 ms current steps that produced
small hyperpolarizing voltage transients after Em was shifted to several values with
longer current injections (> 800 ms). Neuronal input resistance was an increasing
linear function ofEm between values of -100 to -60 mV. Linear regression analyses
were performed on the data obtained over this Em range and a rectification ratio,
RN at -65 mV/RN at -95 mV, calculated from these analyses. On average, RN
determined at -65 mV was twice that determined at -95 mV (Table 1). At Em
values higher than -100 mV, the slope ofRN VS. Em plots decreased smoothly toward
zero. Neuronal input resistance was maximal between Em values of -65 to -55 mV
and usually decreased as Em was depolarized beyond -55 mV.
Stimulation-evoked potentials were recruited in the following characteristic se-
quence as the stimulation intensity was increased: e.p.s.p.s with times to peak of
7-10 ms; i.p.s.p.s with times to peak of 20-25 ms; action potentials (Table 1). Several
lines of evidence indicate that these fast i.p.s.p.s (f-i.p.s.p.s, times to peak of
20-25 ms) are secondary to GABAA-receptor-mediated increases in post-synaptic
chloride conductance (Sutor & Zieglgiinsberger, 1984). Because of the high resting
Em values of rat neocortical neurones in vitro, f-i.p.s.p.s were commonly depolarizing
when evoked at resting Em (Table 1; see also Connors, Gutnick & Prince, 1982).
Whether or not depolarizing f-i.p.s.p.s were evoked with a given stimulation intensity
could be determined by displacing Em with current injections. The post-stimulus
latency to onset of these f-i.p.s.p.s was obscured, however, by the preceding e.p.s.p.s.
The amplitudes of depolarizing potentials evoked with stimulation intensities that
evoked both e.p.s.p.s and f-i.p.s.p.s are therefore referred to as e.p.s.p.-i.p.s.p.
amplitudes, although the amplitudes of these potentials were measured at their peaks
7-10 ms post-stimulus.
In many neurones, stimulation of superficial cortical layers also evoked i.p.s.p.s
with times to peak of 150-250 ms and durations as great as 900 ms. These long
i.p.s.p.s (l-i.p.s.p.s) can also be distinguished from preceding GABAA-receptor-
mediated f-i.p.s.p.s on the basis of their reversal potentials (Ei.p s p.), the dependence
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TABLE 1. Electrophysiological properties of rat neocortical neurones upon which the effects of
baclofen were evaluated. The range and the mean + standard deviation of each parameter and the
number of neurones for which it was evaluated (n) are presented. Abbreviations are defined in the
text
Range Mean + S.D. n
Resting membrane potential -56 to -95 mV -80-4 + 8-3 mV 71
Neuronal input resistance* 10 to 54 MQ2 21-6 + 10 MQ 64
Rectification ratiot 1-2 to 5-4 2-22 + 0 90 19
Action potentials*:
Amplitude 84 to 134 mV 110+ 11 mV 69
Overshoot 15 to 45 mV 30 + 6-8 mV 69
Voltage threshold -41 to -56 mV -48+ 4-8 mV 35
Post-synaptic potentials§
e.p.s.p.s threshold 0 33 to 0-72 0.55+ 0 09 60
f-i.p.s.p.s threshold 0 55 to 1-00 0 79+ 0 09 36
Ei.P.S.P., 500 mM-K+ -65 to -71 mV -68-7+ 1t9 mV 11
Eip s.p, 2-50 mM-K+ -66 to -74 mV -71-3+ 2-5 mV 18
l-i.p.s.p.s threshold 0-67 to 1-00 0-86+ 007 17
Ei. p sp, 5 00 mM-K+ -79 to -86 mV -81-4 + 2-8 mV 6
Ei.p s p, 2-50 mM-K+ -84 to -97 mV - 89-7 + 3-5 mV 11
* Values determined for neurones that were recorded with CsCl-filled electrodes are not included.
t Ratio of RN at Em =-65 mV to RN at Em =-95 mV, which was determined as described
in the text.
I Amplitudes and overshoots are for synaptically evoked action potentials and were measured
from resting Em to peak and from Em = 0 mV to peak, respectively. Voltage threshold refers to
the Em value (referenced to Em = 0 mV) at which action potentials were evoked by direct
intracellular current injections.
§ Threshold values are stimulation thresholds expressed as fractions of the stimulation threshold
of the action potential. Threshold values for e.p.s.p.s are for e.p.s.p.s with times to peak amplitudes
of 7-10 ms post-stimulus.
of their Ei. p sp values on the extracellular potassium concentration, and their
insensitivity to bicuculline (Table 1; Howe, Sutor & Zieglgiinsberger, 1986).
In some neurones, stimulation of superficial cortical layers also evoked e.p.s.p.s
with times to peak of 25-80 ms. These late e.p.s.p.s were always evoked at higher
stimulation intensities than the commonly evoked e.p.s.p.s with times to peak of
7-10 ms, but disappeared as the stimulation intensity was increased further and
i.p.s.p.s were recruited. Thus late e.p.s.p.s were usually only evoked over a narrow
range of stimulation intensities. These late e.p.s.p.s exhibited very sharp stimulation
thresholds and were often irregular in shape and somewhat variable in amplitude.
In a few neurones, however, in which i.p.s.p.s were absent or weak at subthreshold
stimulation intensities, late e.p.s.p.s could be evoked over a wider range of intensities
and their amplitudes were consistent enough to allow the effect of baclofen on these
late e.p.s.p.s to be tested reliably.
The effect of baclofen on e.p.s.p.s
DL- or L-baclofen decreased the amplitude of e.p.s.p.s in fifty-seven of sixty
neurones tested (Fig. 1). Jonophoretic applications of 50-100 nA for 10-30 s resulted
in 29-86% reductions of e.p.s.p amplitudes (52+16%, n = 10). Addition of baclofen
(10 nm to 200,M, see below) to the superfusion medium resulted in 23-100 %
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reductions of e.p.s.p. amplitudes (65 + 25 %, n = 44). Applications of baclofen from
micropipettes by pressure ejection produced similar reductions of e.p.s.p.s (n = 3).
Baclofen-induced reductions of e.p.s.p. amplitudes were associated with 10-80%
increases in e.p.s.p. stimulation thresholds (31 + 15 %; for the calculation of percen-
tage reductions of e.p.s.p. amplitudes, the largest stimulation intensities that did not
evoke i.p.s.p.s were used; the mean reduction of the amplitude of such e.p.s.p.s was
11 mV). Baclofen's percentage reductions of e.p.s.p. amplitudes were independent of
Control Baclofen Recovery
50 nA, 30 s
5Oms N-
Fig. 1. lonophoretically applied baclofen depresses e.p.s.p.s. Voltage transients in re-
sponse to hyperpolarizing current injections (0 2 nA, 50 ms) and e.p.s.p.s evoked with 5 V
stimulation (025 Hz) before (left), during (middle), and 3-5 min after (right) the
ionophoretic ejection of baclofen (50 nA, 30 s). Each picture represents five successive
superimposed oscilloscope sweeps. Note the small hyperpolarization (3 mV) and decrease
in resistance (20%) during baclofen. Control resting Em = -81 mV. The recording
electrode was filled with potassium acetate; the superfusion medium contained 5 00 mM-
potassium. On this and all subsequent Figures, the current monitor was set such that zero
current corresponds to the zero potential and recordings were made in bridge mode unless
stated otherwise.
Em over the range of Em values tested (-60 to -110 mV). The effects of baclofen
on late e.p.s.p.s were quantitatively similar to its effects on e.p.s.p.s with times to
peak of 7-10 ms. Full or partial reversibility of baclofen's reductions of e.p.s.p.s was
demonstrated for thirty-five and twelve neurones, respectively. For ten neurones, the
impalement was lost before recovery was demonstrated.
The effect of baclofen on i.p.s.p.s
DL- or L-baclofen depressed f-i.p.s.p.s in thirty-seven of thirty-nine neurones tested
and l-i.p.s.p.s in seventeen of seventeen neurones tested (Fig. 2). The amplitudes of
f-i.p.s.p.s and l-i.p.s.p.s that were evoked with suprathreshold stimulation intensities
(1-3 x threshold to 2 x threshold) were reduced 22-1000 and 43-100 %, respectively
(median reductions: 80 and 93 %). Determinations of the stimulation threshold of
f-i.p.s.p.s were performed in the absence and presence of baclofen for twenty
neurones. Baclofen increased the stimulation threshold of f-i.p.s.p.s in each neurone
(16-275 00, median: 54 %). The stimulation threshold for evocation of l-i.p.s.p.s was
increased during baclofen in each of six neurones tested (128-2000, median: 146 %).
Baclofen was applied by addition to the superfusion medium on all but two of the
thirty-nine neurones (baclofen concentration: 100 nm to 200#M, see below), and
recovery from baclofen's depression of i.p.s.p.s typically took 30-40 min. Full or
partial recovery of baclofen-induced depressions of i.p.s.p.s was demonstrated for
f-i.p.s.p.s in sixteen and eight neurones and for l-i.p.s.p.s in six and five neurones.
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Control 10 pM-baclofen
A 3 min
16-7 min
_ *@@@X@@P*- *s@@ ¢-
B
I
_2 nA
C 40 mVt ~~~~~~~~~200 ms
Fig. 2. Baclofen depresses i.p.s.p.s. Left, action potential and biphasic hyperpolarizing
potential sequence composed of f- and 1-i.p.s.p.s (A, 2 x threshold stimulation, 0-167 Hz).
The l-i.p.s.p.s can be seen most clearly when Em is shifted to the reversal potential of
f-i.p.s.p.s (C) with hyperpolarizing current injections (0-4 nA, 800 ms). Right, 10/UM-
baclofen hyperpolarized Em from -56 to -62 mV (A) and blocked both f- and l-i.p.s.p.s
at each Em value tested (B). Each trace is two superimposed sweeps. KMeSO4 recording
electrode, 2 50 mM-potassium media.
Baclofen's depressions of i.p.s.p.s were voltage independent between -50 and
-110 mV (Figs. 2, 3 and 5A). Baclofen did not alter Ei p s values ofeither f-i.p.s.p.s
or l-i.p.s.p.s (determinations performed in the absence and presence of baclofen for
twenty-nine and seventeen neurones, respectively). Baclofen did, however, markedly
and reversibly reduce the conductance increases associated with f-i.p.s.p.s and
l-i.p.s.p.s on each neurone tested (n = 9 and 5, respectively). On these same neurones,
baclofen increased resting 9N and decreased direct excitability (Fig. 3). These latter
effects recovered minutes before recovery ofbaclofen's depressions ofthe conductance
increases during i.p.s.p.s (Fig. 4).
Effects of baclofen on synaptic excitability
DL- or L-baclofen increased the stimulation threshold for orthodromically evoked
action potentials in thirty-nine of forty-four neurones tested (6-233 %, median
increase: 27 %). Full or partial reversibility of these effects was demonstrated for
twenty-six and two neurones, respectively. Thus, the predominant effect of baclofen
was to reduce synaptic excitability (Figs. 4C and 5B). At suprathreshold stimulation
intensities, however, there was often an increase in synaptic excitability, as evidenced
by an increase in the number of synaptically evoked action potentials (Fig. 5A). In
cells in which i.p.s.p.s were particularly prominent at subthreshold stimulation
545
PHY 38418
546 J. R. HOWE, B. SUTOR AND W. ZIEGLGANSBERGER
Control 5 piM-baclofen Normal medium
5-10 min 25-30 min
A
0.95 nA El.]l l -T- 1 1-35 nA0,95 nA
6 A/M 10 MQ 8 MQ2
50 ms
DOuMnml Imml11 i|1nA
200 ms
Fig. 3. Baclofen reduces the conductance increases during i.p.s.p.s. Left column: A, action
potentials and depolarizing f-i.p.s.p.-hyperpolarizing l-i.p.s.p. potential sequences evoked
with 2 x threshold stimulation (0 167 Hz) at resting Em (-76 mV, dotted line). B, same
stimulation applied after shifting Em with current injections. C, a 60 ms depolarizing
current step of a magnitude just necessary to evoke an action potential in the absence
of a stimulus was applied at various post-stimulus times to obtain a relative measurement
ofRN during the i.p.s.p. sequences. Values in megaohms are the resistances calculated for
the first post-stimulus measurement. D, same as C, but on a slower time sweep to show
the duration of the post-stimulus inhibition and the reduction in the duration of the
post-stimulus blockade of the directly evoked action potential during baclofen. The
voltage response to the current step in the absence of the stimulus was checked every third
post-stimulus time (note the increase in current magnitude during the measurement
sequence depicted in the bottom right because the control injection failed to produce an
action potential). Middle column: a 10 min application of 5 pM-baclofen hyperpolarized
Em by 6 mV and increased RN by 26 %. The magnitude of the current necessary to evoke
an action potential was increased from 0 95 to 1-35 nA during baclofen (C). Baclofen
produced a voltage-independent reduction of f- and l-i.p.s.p.s (B) and, in contrast to the
decrease in resting RN during baclofen, RN post-stimulus is increased (C and D). Right
column: partial recovery 25-30 min after returning to normal medium. Note different time
calibrations for A, B, C and D. Each trace is two oscilloscope sweeps in A and B and one
sweep in C and D. KMeSO4 recording electrode, 2-50 mM-potassium media.
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A Baclofen
20 AM, 2 min
Control 5 min 10 min 25 min
44V 88V 44V 44V 100ms
12nA
1 4 nA 1-85 nA 1-4 nA 1-2 nA
b
.0m
l4nA 40 s
B C
Control 3min 20min
100 *APT
z 75 vo 22V 59V 24V
cc *5m 444V 9 20smw --.mm
~~25 '1~~0mCnrlm 200mms
01~~~~~mn150 mV
0- v
~~~25 min nA
0 200 400 600 800 50 mV
Time post-stimulus (ms) 200 ms
Fig. 4. Baclofen's reductions of i.p.s.p.s outlast its reductions of resting RN. Aa,
determination of relative RN as a function of post-stimulus time before and at the
indicated times after baclofen with a protocol similar to that depicted in Fig. 3. Stimuli
(0-125 Hz) were applied at the intensities noted below each panel (switched current-clamp
recording (1-2 kHz), therefore one action potential is cut). Ab, responses to current
injections in the absence of a stimulus on a faster time sweep. Current values are those
that produced the action potential (except as indicated by arrow). Other voltage
transients are in response to current injections 0-05 nA less in magnitude. A 2 min
application of 20 /SM-baclofen resulted in a 3 mV hyperpolarization and a significant
decrease in resting RN (Ab, 5 min). RN post-stimulus is markedly increased relative to
control, however, even with a higher stimulation intensity (88 V; Aa, 5 min). This
reduction of the conductance increases during the i.p.s.p. sequences persists at a time (Aa,
10 min) when resting Em and pre-stimulus voltage responses to depolarizing current
injections have returned to their control values (Ab, 10 min). B, plot of the full set of data
from the measurements in A. RN post-stimulus was expressed as a percentage of RN
pre-stimulus which was estimated from the voltage transients that did not produce an
action potential in Ab. Arrows indicate the post-stimulus time at which the directly evoked
spike was not blocked. C, action potentials (bridge mode) evoked at threshold stimulation
intensities (top row, APT as indicated) and with 44 V stimulation (bottom) at the indicated
times relative to the start of the baclofen application. Bottom left, 44 V stimulation
applied after displacing Em with current injections. Control resting Em =-87 mV.
KMeSO4 recording electrode, 2-50 mM-potassium media.
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A Control
a 16V
b 25V
c 25V
Baclofen
100luM, 2 min
4
Normal medium
55 min
K'H~ | 40 mV
40 ms
50mV
100 ms
I
I20mV
100 ms
B Baclofen, 100 pM for 3 min
40 0 Control
* Normal medium, 1 min
0. 30 v Normal medium,
,Q E 55mm
.10
V
1
20 -
a-aa4;E 10 -7co
10 15 20 25
Stimulus intensity (V)
Fig. 5. Effect of baclofen on synaptic excitability. Aa, left, depolarizing e.p.s.p.-i.p.s.p.
sequence evoked at subthreshold stimulation (16 V, 0-25 Hz; resting Em = -84 mV). This
potential sequence is reduced in amplitude during a 2 min application of 100 ,uM-baclofen
(top middle). The stimulation intensity required to produce one action potential increased
from 17 to 20 V. Suprathreshold stimulation (25 V) evokes prominent depolarizing
f-i.p.s.p.s before baclofen (Ab, left) which reverse in polarity at -70 mV (Ac, left: switched
current-clamp mode current traces not shown). The biphasic nature of the hyperpolarizing
i.p.s.p. sequence indicates that this intensity (25 V) also evokes l-i.p.s.p.s. Baclofen blocks
these i.p.s.p.s at all Em values tested (Ac, middle) and 25 V stimuli during baclofen
produce a burst of three action potentials (Ab, middle). Right, recovery 55 min after
switching back to normal medium. Each trace is two superimposed sweeps. B, plot of
stimulation intensity v8. amplitude of the depolarizing e.p.s.p.-i.p.s.p. sequence to action
potential threshold (APT, arrows) from measurements made on another neurone (resting
Em =-86 mV). A 3 min application of 100 luM-baclofen caused a marked and reversible
shift to the right of the input-output curve 1 min after baclofen. Potassium acetate
recording electrodes, 5 00 mM-potassium media.
intensities, the increases of action potential threshold produced by baclofen were
modest, or this threshold was even reversibly decreased (6-20 %, n = 4).
Effects of baclofen on Em and RN
Applications ofDL- or L-baclofen produced hyperpolarizations (1-12 mV, 4 + 2 mV)
in forty of seventy-one neurones. Complete reversibility of these hyperpolarizations
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Fig. 6. Reversal potential of baclofen-induced changes in Em. A, changes ofEm produced
by the ionophoretic application of baclofen at resting Em (-76 mV) and after displacing
Em to the indicated values with constant-current injection. B, plots for determination of
EBAC for the cell in A and for three other cells. The range of EBAC values is -89 to
-92 mV. All determinations were made in 5 00 mM-potassium media and with potassium
acetate recording electrodes.
was demonstrated for thirty-five neurones. Depolarizations in response to baclofen
were never observed when baclofen was applied at resting Em. In each of seven
neurones on which ionophoretic applications of both GABA and baclofen were made
at resting Em, GABA produced depolarizations and baclofen produced hyper-
polarizations.
The amplitude of baclofen-induced hyperpolarizations was increased when Em was
depolarized, and in four neurones it was possible to hyperpolarize Em far enough to
reverse these hyperpolarizations. Determinations of the reversal potential (EBAC) of
Em changes produced by ionophoretically applied baclofen were between -89 and
-92 mV in 5 mM-potassium medium (Fig. 6). Estimations of EBAC were also made
from the intersection point of current-voltage relation plots determined in normal
and in baclofen-containing media for another fifteen neurones (Ginsborg, 1967). Mean
EBAC values so estimated were -85 + 6 mV and -97 +5 mV in 5 00 and 2-50 mM-
potassium media, respectively (n = 8 and 7; values significantly different from each
other, P < 0 005). The amplitude of baclofen-induced hyperpolarizations was in-
creased when the potassium concentration of the medium was reduced from 5 00
to 1-25 mm and the EBAC values estimated from the intersection point of current-
voltage relations plots were shifted by -21 and -24 mV.
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For twenty-nine of the forty neurones hyperpolarized by baclofen, reductions in
RN were measured during these hyperpolarizations (10-58 %, 26+10 %). These RN
decreases were not solely the consequence of the anomalous rectification inherent to
the neurones, because significant decreases in RN remained when constant current
was injected to shift Em back to its pre-application value. Furthermore, in only a
few cases were the hyperpolarizations large enough for the inward rectifying
behaviour of the cells to influence significantly the magnitude of the RN decreases
measured. The most exceptional case was the 58% reduction in RN measured in a
neurone that baclofen hyperpolarized from -69 to -81 mV. In seven neurones, RN
decreases were not detected during the small hyperpolarizations produced by
baclofen, and reversible decreases in RN (15-30%) were measured in six neurones that
were not hyperpolarized by baclofen.
Current-voltage relation determinations in normal and in baclofen-containing
media were made for fifteen neurones. In four cases, comparisons of the resultant
10-30 point plots suggested that the absolute decrease in RN produced by baclofen
was greatest at hyperpolarized Em values. In the other eleven cases however, these
comparisons gave no indication that baclofen-induced RN changes were voltage
dependent. Determinations of the dependence of RN on Em were made (as described
in the first section of the Results) in both normal and in baclofen-containing media
for eight neurones. These measurements also did not indicate that there was any
significant or consistent voltage dependence of the RN decreases measured during
baclofen.
Importantly, in virtually every neurone tested, the hyperpolarizations and de-
creases in RN produced by baclofen recovered before the baclofen-induced depressions
of post-synaptic potentials (Fig. 8). The effects of baclofen on synaptically evoked
potentials often outlasted its effects on Em and RN by several minutes.
Effects of baclofen on neurones recorded in voltage clamp
Outward currents in response to ionophoretically applied baclofen or to short bath
applications of high concentrations of baclofen were recorded in somatic voltage
clamp at holding potentials of -55 to -65 mV in three of four neurones tested
(Fig. 7). These outward currents were associated with 10-20% increases in 9N. The
currents had kinetics similar to the baclofen-induced hyperpolarizations recorded in
current clamp from the same neurones and were of sufficient magnitude to account
for the magnitude of these hyperpolarizations. Applications of baclofen did not
produce measurable currents in either of two cells clamped at a holding potential of
-80 mV in 5 mM-potassium medium (Fig. 10).
Efects of baclofen on direct excitability
DL- or L-baclofen increased the magnitude of the depolarizing current necessary
to evoke an action potential for twenty-three of twenty-seven neurones tested
(11-50 %, 30+ 13 %). Full reversibility of these reductions in direct excitability was
demonstrated for seventeen neurones. Baclofen did not change the threshold voltage
for action potential generation and had no noticeable effects on action potential rise
time or duration. Increases ofdirect excitability during baclofen were never observed.
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Fig. 7. Outward currents underlie the hyperpolarizations produced by baclofen. A, a 15 s
application of 200 /LM-baclofen (bars below voltage trace) produces an outward current
(upper trace) in a neurone voltage clamped at a holding potential of -60 mV (switching
frequency: 1-7 kHz). Downward deflexions on the current trace are inward current
responses to 10 mV hyperpolarizing command steps. The apparent magnitudes of these
currents are cut by the frequency response of the pen writer; however, comparison of the
amplitudes of the indicated responses that were photographed from the oscilloscope
(below) demonstrates that during the baclofen-induced outward current there is a 10-15%
increase in gN. B, another application of baclofen (200 /LM, 15 s, bar) produces a similar
outward current (holding potential: -55 mV). Downward deflexions on the current trace
represent inward currents evoked in response to ionophoretic applications of L-glutamate
(90 nA, 700 ms, at arrowheads below voltage trace). These inward currents were unchanged
during the baclofen-induced outward current. The indicated inward currents are super-
imposed in the photographs below (L-glutamate applications indicated by bars above
current traces). The outward currents evoked by baclofen in this neurone had kinetics that
were similar to those of the hyperpolarizations produced by similar baclofen applications
made during current-clamp recording at resting Em (-66 mV; see Fig. 8D). KMeSO4
recording electrode, 2-50 mM-potassium media.
Effects of baclofen on responses evoked by excitatory amino acids or GABA
Applications of baclofen that markedly reduced e.p.s.p.s produced no or only slight
(< 20 %) reductions of depolarizations evoked by the ionophoretic application of
L-glutamate (eight neurones tested, Figs. 8 and 9). The percentage reductions of
L-glutamate-induced depolarizations that were observed were similar in magnitude
to the percentage reductions of RN measured during the baclofen applications; and,
like RN, depolarizations produced by L-glutamate recovered to control values
minutes before the recovery of baclofen-induced depressions of e.p.s.p.s. Applications
ofbaclofen that markedly reduced the amplitudes ofe.p.s.p.s also did not significantly
reduce depolarizations produced by L-aspartate or NMDA (four applications on three
neurones, Fig. 9). Applications of baclofen that markedly reduced e.p.s.p.s recorded
in current clamp, produced no change in the amplitude of L-glutamate-induced
inward currents recorded from these same neurones in somatic voltage clamp (n = 2,
Fig. 7B).
Baclofen applications that completely and reversibly blocked f-i.p.s.p.s evoked
with suprathreshold stimulation intensities had no effect on depolarizations produced
in the same neurones by ionophoretic applications of GABA (n = 3). The decreases
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Baclofen
A 200 pM, 18 s
Control 2 min 15 min
Glutamate _ J_ 500 mv500 ms
14 V 4 110 mV10 ms
C
APT 50 mV
15V 50V 18V 20ms
20 ms
Baclofen Baclofen 50 ms
Fig. 8. Baclofen's depressions of e.p.s.p.s can be dissociated from its effects on Em and
on depolarizations evoked by L-glutamate. A (glutamate), depolarizing responses (each
four superimposed sweeps) to ionophoretic applications of L-glutamate (80 nA for 700 ms,
bars) before and at the indicated times after an 18 s application of 200 ,LM-baclofen
(application time indicated by the bar below the chart records shown at the bottom of
the Figure). B (14 V), e.p.s.p.s evoked with 14 V stimulation (010 Hz) at the times
indicated on the chart record ofEm on D, left (record D, right, depicts the same application
at a different time calibration; pen-writer deflexions in response to stimulation-evoked
potentials have been touched out of the records to enhance the clarity of presentation).
Picture 1 and the e.p.s.p.s 15 min after baclofen are four superimposed sweeps. Pictures
2, 3, 4 and 6 are each one sweep. In order that the amplitudes of the e.p.s.p.s can be better
compared, the potentials were replayed at the same offset level when the photograph was
made. C, action potentials at the indicated threshold stimulation intensities (APT). Note
that APT is still increased more than 3-fold after Em has repolarized (picture 5) and that
e.p.s.p.s remain markedly reduced at a time (6) when the depolarizations evoked by
L-glutamate are hardly affected. This Figure depicts an earlier baclofen application made
on the neurone that is depicted in Fig. 7.
in RN associated with these depolarizations were also unaffected by baclofen.
Importantly, baclofen (three applications on two neurones) had no effect on inward
currents produced by GABA during voltage-clamp recordings (Fig. 10).
Reproducibility and concentration dependence of baclofen effects
The reproducibility of baclofen's effects on post-synaptic potentials and on Em and
RN were most easily demonstrated when baclofen was applied by ionophoresis, as the
effects were then relatively short-lived. The prolonged depressions of post-synaptic
potentials produced by bath applications of baclofen limited the possibilities for
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120 mV
Aspartate 0 0 0 0 0 0 ° 1 minAIL A, AA
Glutamate
25 pM-baclofen
Control 2 min 5 min Recovery J 20 mV
Fig. 9. Baclofen does not depress responses to ionophoretically applied excitatory amino
acids. Chart records of depolarizing responses to ionophoretic applications of NMDA
(75 nA for 6 s), L-aspartate (100 nA for 10 s), or L-glutamate (100 nA for 10 s). Action
potentials during the NMDA depolarizations are cut by the frequency response of the pen
writer. Upward vertical lines are pen-writer deflexions in response to post-synaptic
potentials evoked with various stimulation intensities. Pictures below the chart record
depict e.p.s.p.s (note presence of late e.p.s.p.s which are seen most clearly in the picture
labelled 2 min) that were evoked with 11 V stimulation before, 2 and 5 min into, and
20 min after the indicated 7 min application of 25 /LM-baclofen (six, two, two and five
successive superimposed sweeps, respectively). In contrast to the almost complete
depressions of e.p.s.p.s, depolarizations produced by either of the three excitatory amino
acids are unchanged by baclofen. Resting Em =-84 mV. Potassium acetate recording
electrode, 5 00 mM-potassium media.
Baclofen Normal medium
Control 20 pM, 5 min 15 min 0-25 nA
GABA, 100 nA 10 mV
Fig. 10. Baclofen does not reduce inward currents evoked by ionophoretically applied
GABA. Inward currents recorded in somatic voltage clamp (switching frequency:
10-8 kHz) at a holding potential of -80 mV in response to ionophoretic applications of
GABA (bars, 100 nA for 600 ms). Each trace is the digitized computer average of five
successive responses recorded before, 5 min into and 15 min after a 6 min application of
20 /SM-baclofen. The resting Em of the neurone was -78 mV and when the same GABA
applications were made in current clamp they produced 7-8 mV depolarizations. This
same baclofen application completely and reversibly blocked suprathreshold f-i.p.s.p.s
recorded from the neurone in current clamp. Potassium acetate electrode, 5-00 mm-
potassium media.
repeated testing; however, more than one such application was made on eighteen
neurones and the results from these neurones also demonstrated convincingly the
reproducibility of baclofen's effects and provided no evidence for significant de-
sensitization.
In order to increase the possibility of demonstrating full recovery, high concen-
trations of baclofen were applied for short times in some experiments. In our
experience, however, steady-state responses to changes in the ionic composition of
the medium or to bath-applied baclofen are only reached after application times of
5-10 min with our superfusion system. Therefore only applications of baclofen-
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Fig. I11. The EC50 for baclofen's reductions of e.p.s.p.s and direct excitability is ap-
proximately 1 ,M. A, concentration-response curves: -log baclofen concentration v8.
percentage reduction of e.p.s.p. amplitudes (0, left) or percentage reduction of direct
excitability (O, right; calculated from the percentage increase in the depolarizing current
magnitude necessary to produce an action potential). Points represent the mean percent-
age reductions of each parameter calculated from the data obtained during baclofen
superfusions >, 5 min in duration. The number of such applications of each concentration
is indicated by the number next to each data point (the data from one application of
3 ,cm-baclofen were averaged together with the data from five applications of5 ,um-baclofen
to yield the points plotted at 5 um). The curve was fitted by eye through the e.p.s.p. data.
The approximate EC50 for eacl rction of baclofen is 1.M. Note the difference between
the maxima of the scales. B, e.p.s.p.s evoked with 12-5 V stimulation before (control) and
during applications ofthe indicated concentrations ofbaclofen, and 30 min after returning
to normal medium (wash). Note the two-component nature of the e.p.s.p.s. Late e.p.s.p.s
could be evoked in control at all stimulation intensities betweenrpe V and action potential
threshold (14 V) and were of consistent amplitude at each intensity. The superfusions with
baclofen-containing media were 1w28 min in duration and were made in consecutive
ascending order of concentration without intermediate washes. The depicted e.p.s.p.s were
all evoked after at least 12 min of superfusion with the indicated baclofen concentration.
Membrane potenti salues were (from upper left to lower right):i-83,b-o83,-(85,c -87,
-d89,i-91,a-92 ands-87 mV. Potassium acetate recording electrode,23 5 mm-potassium
media.
containing medium of > 5 min were considered in the analysis of the concentration
dependence of baclofen's actions.
Fig. (1Apresents a concentration-response eaurve for baclofen's depression of
e.p.s.p.s based on the mean data from all applications of >w5 min. The results indicate
that the threshold concentration for baclofen's reductions of e.p.s.p. amplitudes is
between 10 and 100 nm and that the ECs50 for baclofen's depression of e.p.s.p.s is
approximately IptM. The results from experiments in which it was possible to make
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Fig. 12. Baclofen's depressions of e.p.s.p.s and i.p.s.p.s are stereoselective. A, plot of the
amplitude of the depolarizing e.p.s.p.-i.p.s.p. sequence evoked at 24 V stimulation
(0-8 x threshold, 0-25 Hz) vs. time. Applications of L- or D-baclofen are indicated by the
bars above the plot. 1 /tM-L-baclofen depressed the e.p.s.p.-i.p.s.p. amplitude by 50% and
increased the action potential stimulation threshold (APT) by 20%. D-Baclofen (10 ,UM)
did not alter the e.p.s.p.-i.p.s.p. amplitude nor APT. L-Baclofen produced a 3 mV
hyperpolarization. Control resting Em was -84 mV. B, top row, action potentials and
depolarizing f-i.p.s.p.-hyperpolarizing l-i.p.s.p. sequences evoked by 30 V stimulation
(0-25 Hz) before, during and after a 10 min application of 100 fsM-D-baclofen. Bottom row,
stimuli applied after displacing Em with 800 ms current injections. All traces are two
superimposed sweeps. 100 ,sM-D-baclofen had no effect on the i.p.s.p. sequence. This
D-baclofen application also had no effect on: the complete e.p.s.p.-i.p.s.p. input-output
relation; APT; Em; or direct excitability. Control resting Em =-82 mV. KMeSO4
recording electrodes, 2-50 mM-potassium media.
applications of several concentrations on the same neurone support these conclusions
drawn from the pooled data (Fig. 11 B).
Similar results were obtained with regard to baclofen's depression of i.p.s.p.s.
10-20% increases in i.p.s.p. stimulation thresholds were observed with baclofen
concentrations of 100-300 nm. Mean depressions of the amplitudes of suprathreshold
f-i.p.s.p.s were 38, 76, 89 and 93% at concentrations of 1 ,UM (n = 2), 3-5 ,UM (n = 6),
10/tM (n = 8), and 20-25 #M (n = 3), respectively. Concentrations of baclofen of
1-5 ,UM reduced the amplitudes of suprathreshold l-i.p.s.p.s by 46-100% (n = 5), and
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D-Baclofen Normal L-Baclofen
Control 100pM, 10 min medium W0M, 10 min
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13 V
APTAPAPI
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26 VI
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c 10- / V D-Baclofen
W E 0 Normal medium
V L-Baclofen 52 V0 - ~ , . 50 mV
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Fig. 13. Baclofen stereoselectively reduces synaptic excitability. Action potentials and
post-synaptic potential sequences evoked at the indicated stimulation intensities (in volts;
frequency, 0-25 Hz). A 10 min application of 100 #M-D-baclofen does not alter the action
potential threshold (APT). Depolarizing f-i.p.s.p.s evoked with 26 V stimulation are
modestly reduced in amplitude. 10 ,uM-L-baclofen (10 miti) more than doubles APT and
during L-baclofen there is no evidence of depolarizing f-i.p.s.p.s even with stimulation at
52 V intensity. Each trace is two superimposed sweeps. Inset, plots of the input-output
relations for the e.p.s.p.-i.p.s.p. sequence to APT that were determined during superfusion
with the indicated media. Resting Em =-83 mV. KMeSO4 recording electrode, 2-50 mm-
potassium media.
100% depressions of suprathreshold l-i.p.s.p.s were observed for each neurone on
which baclofen concentrations of 10-20 /,M were applied (n = 4).
Measurable hyperpolarizations and RN decreases were obtained with baclofen
concentrations of 100-300 nm. There were no significant differences between the mean
amplitudes of baclofen-induced hyperpolarizations and RN decreases that were
obtained with baclofen concentrations between 1 and 25 /tM; however, effects of
baclofen on Em and RN were observed more consistently as the baclofen concentration
was increased over this range.
In our hands, the increase in the magnitude of the depolarizing current required
to produce an action potential was the most sensitive and reliable indicator of
baclofen's effects on Em and RN. Fig. 11 A also presents a concentration-response
curve for baclofen's depressions of direct excitability based on the mean data
obtained from twenty-three applications on twelve neurones. The results indicate
that the EC50 for baclofen's reductions of direct excitability is approximately 1 /tM.
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Stereoselectivity of baclofen's effects
The effects of L- and D-baclofen were compared on six neurones. Each ofthe actions
of baclofen was clearly stereoselective. Applications of 1-10 ISM-L-baclofen produced
depressions of e.p.s.p.s and i.p.s.p.s, Em and RN changes and decreases in synaptic
and direct excitability that were similar in magnitude to those produced on other
neurones by the same concentrations of DL-baclofen, whereas applications of D-
A Normal Normal
Control 10pM-o-baclofen medium 1 pM-L-baclofen medium- 1 |$ "-w- * -rw 3 -- |2 nA
40 ms
B a V (mV) / C/V
30- h
n Barloien, 10,UM L Baciofen, 1 uM /
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v
V Normal medium, 40 min
v L-Baclofen, 1 plM, 10 min
0
_~~~20 El Normal medium, 25 min
Fig. 14. Baclofen's effects on Em and RN are stereoselective. A, measurements of
current-voltage relations (two sweeps each trace except for those with action potential).
B, current-voltage relations before, during and 40 min after a 12 min application of
10 /LM-D-baclofen and during and 25 min after a 12 min application of 1 ,#M-L-baclofen.
Continuous curve was fitted by eye through control and 40 min normal medium data
points. Dashed curve was fitted by eye through L-baclofen data points. Em (mV) and RN
(MQ) values (determined from the slope at the origin of the curves fitted for each of the
five sets of data) were: control, -91 and 20; D-baclofen, -91 and 20; normal medium
40 min, -91 and 19; L-baclofen, -95 and 15; normal medium 25 min, -93 and 18. Inset,
plot of rheobase current v8. time from determinations made on the same cell. D- and
L-baclofen applications are indicated by the bars above the plot. KMeSO4 recording
electrode, 2-50 mM-potassium media.
baclofen at 10-30-fold higher concentrations produced no significant effects on any
of these parameters (Figs. 12, 13 and 14). On each of the five neurones tested, 10 min
applications of 100 /SM-D-baclofen did not produce any significant effects on Em, RN,
or direct excitability, and synaptically evoked potentials were either unaltered or
were onl.y slightly reduced (< 20 %). Because the EC50 for each action of DL-baclofen
is approximately 1 ,UM, these results indicate that L-baclofen is more than 100-fold
J. R. HOWE, B. SUTOR AND W. ZIEGLGANSBERGER
a Normal medium
Control
b Bicuculline, 10pM
Control
Baclofen, 70 nA
Baclofen, 70 nA
GABA, 80 nA
Control
Bicuculline,
100 eM
Normal
medium
Recovery
Recovery
20 mV
40 ms
Baclofen, 60 nA
10 mV
30 s
Fig. 15. Baclofen's effects on e.p.s.p.s and on Em and RN are resistant to blockade by
bicuculline. Aa, e.p.s.p.s evoked at 5 V stimulation (0-25 Hz) before, during and 90 s after
the ionophoretic application of baclofen (70 nA, 15 s) while superfusing with normal
medium. Baclofen reduces the amplitude of the e.p.s.p.s by 40 %. Ab, a 30 min application
of 10 /uM-bicuculline increased the amplitude of e.p.s.p.s evoked with 5 V stimulation, but
the relative reduction (36%) of these e.p.s.p.s by baclofen is not significantly changed.
Resting Em =-86 mV. Each trace is two superimposed sweeps. B, chart records of Em
(resting Em =-84 mV). Downward vertical deflexions are pen-writer responses to voltage
transients produced by rectangular hyperpolarizing current injections (0 5 nA, 150 ms).
GABA or baclofen were applied by ionophoresis at the indicated ejection currents for 10 s
(bars below records). Baclofen applications were made approximately 1 min after the
corresponding GABA application while: superfusing with normal medium (control, Ba),
20 min after switching to a medium that contained 100 /uM-bicuculline (Bb) and 40 min
after returning to normal medium (Bc). GABA (control) depolarizes Em and produces a
marked decrease in RN. Both the depolarization and the RN decreases are almost
completely and reversibly blocked by bicuculline. At the same Em, baclofen produces a
hyperpolarization and a small decrease in RN that are not altered during bicuculline.
Potassium acetate recording electrodes, 2-50 mM-potassium media.
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A Baclofen200 pM, 10 s Bicuculline
Control f 110 s 15 min 50pM, 6 min
aiV IjII--Ia 15V
APT 50 ms
b 32 V
3-4 min
11 nA
c 32V 50mV
B
Baclofen
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Fig. 16. Baclofen's depressions of synaptic excitability are resistant to blockade by
bicuculline. A, column 1 (control): a, voltage transients in response to hyperpolarizing
current injections (05 nA, 150 ms) and action potentials at stimulation threshold
(APT = 15 V); b, action potentials and f-i.p.s.p.-l-i.p.s.p. sequences evoked with 32 V
stimulation; c, stimuli (32 V) applied after displacing Em with current injections (800 ms).
Column 2, a 10 s application of 200,uM-baclofen blocks the stimulation-evoked action
potentials (APT = 19 V at 130 s) and causes a 5 mV hyperpolarization and a 31 % decrease
in RN (a, 110 s). 3-4 min later, i.p.s.p.s are still markedly depressed (b and c). Column 3,
reversal of these effects of baclofen 15 min post-application. Column 4, the superfusion
medium was switched to one that contained 50 /M-bicuculline. 6 min later, 15 V stimu-
lation produces five spike bursts (a) and 32 V stimulation produces 'giant' e.p.s.p.s during
which action potentials are inactivated (b). All traces in A are two superimposed sweeps.
Control resting Em = -76 mV. B, top left, same neurone 14 min into the bicuculline
application (Em = -74 mV). Stimulation at 9-8 V intensity produces 6 mV e.p.s.p.s and a
9-9 V stimulus produces a seven-spike burst of action potentials. Columns 2 and 3, an
application of baclofen identical to that in A reduces the amplitude of the e.p.s.p.s evoked
with 9-8 V stimulation, causes a 6 mV hyperpolarization, and increases the threshold for
the action potential burst (bottom row). All these effects are reversible 14 min post-
application of baclofen (top right). The responses to 9-8 V stimulation are all four
superimposed sweeps. Responses at the other stimulation intensities are each one sweep.
KMeSO4 recording electrode, 2-50 mM-potassium media.
559
J. R. HOWE, B. SUTOR AND W. ZIEGLGANSBERGER
Control Baclofen Baclofen
1 CsCI, 20 min 2 200 JAM, 3 min 200 JM, 8 min
10 s
Baclofen
-,150
__1 1nAE
0j1 50 50 mV
0 5 10 15 20 40 ms
8 Time (min)
Normal medium 10 mM-TEA
12 nA
Control ,
,50 mV
20 ms
10 m-E
50 OMm-baclofen
2 min 30-90s 2 min 4min
Fig. 17. Baclofen does not reduce the duration of the calcium component of action
potentials prolonged with caesium or TEA. A, recording with a CsCl electrode. Top left,
20 min into the recording after injecting the cell several times with caesium ions, a
depolarizing current step (0 4 nA, 400 ms) evokes action potentials of prolonged duration
(135 ms at Em =-30 mV). Middle and right, action potentials evoked 3 and 8 min into
the application of 200 /aM-baclofen. Each picture in the top row is ten successive
superimposed sweeps. Bottom left, plot of action potential duration (at Em = -30 mV)
vs. time. The 10 min baclofen application is indicated by the bar. Right, two successive
sweeps each at times 1, 2 and 3 in the top row that are superimposed for better comparison
(resting Em = -71, -68 and -67 mV, respectively). B, top (control), action potentials
evoked by depolarizing current injections (1-55 nA) before (left, one sweep) and 13 min
after (right, five sweeps) switching to a superfusion medium that contained 10 mM-TEA.
Bottom left, superimposed sweeps 30, 50, 62, 70, 78, 82, 86 and 90 s after switching to
TEA + 50 /aM-baclofen medium, action potentials at 30-86 s are left to right and at 90 s
the current injection failed to produce an action potential. Middle and right, the current
magnitude was increased (to 1-80 nA) to evoke an action potential. The duration of these
action potentials was not reduced either 2-4 min after starting the 2 min baclofen
application (pictures are four sweeps each). Resting Em = -88 mV (normal medium),
-85 mV (TEA). KMeSO4 recording electrode, 2-50 mM-potassium media.
more potent than D-baclofen at producing each of the effects observed. The potency
of DL- and L-baclofen were not compared directly on the same neurones; however,
they appeared to be approximately equipotent.
Effects of bicuculline on the actions of baclofen
Applications of the GABAA receptor antagonist bicuculline that completely
blocked f-i.p.s.p.s and responses to ionophoretically applied GABA had no effect on
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baclofen's depressions of e.p.s.p.s (Fig. 15A) or on baclofen-induced hyperpolariza-
tions and reductions of RN (Fig. 15B). Bicuculline was applied at concentrations
of 10-100 gm. Applications of 1 /LM-bicuculline are sufficient to markedly reduce
f-i.p.s.p.s or the responses of rat neocortical neurones to ionophoretically applied
GABA or the GABAA agonist muscimol.
Although both compounds blocked f-i.p.s.p.s, the effects of baclofen and bicuculline
were clearly different. On each neurone tested (n = 7), baclofen decreased synaptic
excitability, whereas bicuculline increased it (Fig. 16A). Baclofen increased the
stimulation threshold for the bursts of action potentials that were recorded in the
presence of bicuculline (Fig. 16B).
Effects of baclofen on somatic calcium spikes
Intracellular injections of caesium ions or superfusion with medium that contained
10 mM-TEA prolonged the duration of directly evoked action potentials 15-100-fold.
The duration of such action potentials is reduced reversibly by manganese or cobalt
ions, indicating that the increased duration is due to the inward movement of calcium
ions when spike repolarization is inhibited. Applications of high concentrations of
baclofen (50-200 /zM) did not alter the duration of action potentials recorded in the
presence of caesium or TEA in any of the neurones tested (n = 4, Fig. 17).
DISCUSSION
Effects of baclofen on stimulation-evoked post-synaptic potentials
The depression by baclofen of e.p.s.p.s is consistent with reports from investigations
in other regions of the mammalian C.N.S. (Pierau & Zimmermann, 1973; Fox et al.
1978; Blaxter & Carlen, 1985; Haas, Greene & Olpe, 1985; Inoue, Matsuo & Ogata,
1985 b). As mentioned, the f-i.p.s.p.s we record in rat neocortical neurones are
mediated by GABAA receptors (Sutor & Zieglgainsberger, 1984). Baclofen also reduces
GABAA-receptor-mediated i.p.s.p.s evoked in neurones in the hippocampus and in
the olfactory cortex (Misgeld et al. 1982; Scholfield, 1983; Blaxter & Carlen, 1985;
Inoue et al. 1985b). The l-i.p.s.p.s we record resemble closely the long-duration (slow)
i.p.s.p.s that are recorded from hippocampal pyramidal cells. Baclofen reduces the
amplitude of slow i.p.s.p.s in CAI and CA3 pyradimal cells (Blaxter & Carlen, 1985;
Inoue et al. 1985 b).
The principal effect of baclofen on rat neocortical neurones was to reduce synaptic
excitability, although baclofen reduced both f-i.p.s.p.s and l-i.p.s.p.s. Baclofen also
increased action potential stimulation thresholds in previous intracellular studies
(Pierau & Zimmermann, 1973; Fox et al. 1978; Haas et al. 1985). although some
investigators report that baclofen both increased and decreased action potential
thresholds, depending on the cell population investigated and the concentration of
baclofen applied (Misgeld et al. 1982; Inoue et al. 1985b).
The consistency of the increases in action potential stimulation threshold that we
observed is in part explained by the characteristic sequence in which post-synaptic
potentials are recruited in rat neocortical neurones with the stimulation we employed.
Post-synaptic potential sequences evoked with subthreshold stimulation intensities
are dominated by e.p.s.p.s, and baclofen's action to depress e.p.s.p.s is therefore of
more consequence for these potential sequences than is its action to depress i.p.s.p.s.
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In addition, baclofen decreased the direct excitability of most neurones tested and
this effect also contributes to the action of baclofen to increase the stimulation
threshold of the synaptically evoked action potential.
Effects of baclofen on Em and RN
The mean reversal potential of baclofen-induced changes in Em and the dependence
ofapparent EBAC on the extracellular potassium concentration suggest these changes
are secondary to an increase in the conductance of the post-synaptic membrane to
potassium ions. Studies of the hyperpolarizing action of baclofen on hippocampal
neurones (Newberry & Nicoll, 1984, 1985; Giihwiler & Brown, 1985; Inoue et al.
1985a) and on neurones in the dorsolateral septal nucleus (Stevens, Gallagher &
Shinnick-Gallagher, 1985) have shown convincingly that baclofen directly increases
the potassium conductance of these cells. The magnitude of the hyperpolarizations
produced by baclofen in our experiments was typically only 2-6 mV. Larger
amplitude hyperpolarizations in response to baclofen have been reported for other
C.N.S. neurones (Misgeld et al. 1982; Brady & Swann, 1984; Pinnock, 1984; Haas
et at. 1985; Inoue et al. 1985a; Newberry & Nicoll, 1985). The magnitudes of the
decreases in apparent input resistance we observed were, however, very similar to
those produced by baclofen in other c.N.s. neurones (Newberry & Nicoll, 1984;
Blaxter & Carlen, 1985; Haas et al. 1985; Inoue et at. 1985 a). The smaller amplitude
hyperpolarizations we observed are therefore probably accounted for by the higher
resting Em values of the neurones we recorded.
In cultured hippocampal neurones, baclofen-induced currents exhibit inward
rectification (Giihwiler & Brown, 1985). We recorded baclofen-induced outward
currents at holding potentials of -55 to -65 mV, but we did not examine their voltage
sensitivity. Inoue et al. (1985a) also concluded that baclofen-induced conductance
changes exhibit inward rectification from their comparisons of control current-
voltage relations (obtained during current-clamp recordings) to those obtained in the
presence of baclofen. Our similar comparisons of current-voltage relations did not,
in most cases, suggest that the conductance increases produced by baclofen were
voltage dependent; nor did our estimations ofRN from single hyperpolarizing current
steps applied at several different Em values provide any consistent evidence for such
voltage dependence. The baclofen-induced decreases in RN were commonly quite
modest, however, and the interpretation of such current-clamp measurements is
complicated by the rectifying behaviour of the neurones themselves. As such, we
believe that these results do not exclude a voltage dependence of the baclofen-induced
conductance increases we observed. In all major respects, the conductance increases
produced by baclofen in rat neocortical neurones are similar in character to those
produced by baclofen in other central neurones. This action of baclofen results in
decreases in direct excitability.
Pharmacology of baclofen actions
Our results indicate that the EC50 value for each action of baclofen observed is
approximately 1 UM. This is similar to estimated EC50 values for baclofen actions
observed in other electrophysiologic studies (Ault & Nadler, 1982, 1983; Collins,
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Anson & Kelly, 1982; Inoue et al. 1985a; Newberry & Nicoll, 1985). Depressions of
e.p.s.p.s and i.p.s.p.s and hyperpolarizations and decreases in direct excitability
became evident at concentrations of 10-100 nm, concentrations of baclofen that are
approximately equal to those obtained in the cerebrospinal fluid after systemic
administration of therapeutic doses in man (Knutsson, Lindblom & Martensson,
1974; Swahn, Beving & Sedvall, 1979).
Each action of baclofen was more than 100-fold stereoselective. Quantitatively
similar estimations have been made for the stereoselectivity of baclofen actions
observed in other electrophysiologic studies (Ault & Nadler, 1982, 1983; Brady &
Swann, 1984; Haas et al. 1985; Inoue et al. 1985a; Newberry & Nicoll, 1985). Given
the extent of this stereoselectivity, L-baclofen should be approximately twice as
potent as DL-baclofen. The range of L-baclofen concentrations we applied and the
number of neurones we tested were too small, however, to allow us to accurately
discriminate a difference in potency of this magnitude. The results of further
experiments do indicate, however, that as expected L-baclofen is slightly more potent
than DL-baclofen on neocortical neurones (Howe & Zieglgiinsberger, 1986).
In agreement with previous reports, baclofen-induced hyperpolarizations and
decreases in RN were insensitive to blockade by concentrations of the GABAA
receptor antagonist bicuculline between 10 and 100 /SM (Brady & Swann, 1984;
Newberry & Nicoll, 1984, 1985; Pinnock, 1984; but see Inoue et al. 1985b). Baclofen-
induced outward currents are also not reduced by GABAA receptor blockade
(Giihwiler & Brown, 1985).
It was concluded on the basis ofextracellular recordings that baclofen's depressions
of excitatory synaptic transmission are not blocked by GABAA receptor antagonists
(Ault & Nadler, 1982; Cain & Simmonds, 1982; Collins et al. 1982; Inoue et al. 1985b).
Our intracellular results which demonstrate that baclofen's depressions of e.p.s.p.s
are resistant to antagonism by bicuculline provide directSupport for this.
Although baclofen blocked i.p.s.p.s, the actions of baclofen and bicuculline on rat
neocortical neurones were not synergistic, as they were reported to be on hippocampal
granule cells (Misgeld et al. 1982). Thus, bicuculline consistently and significantly
decreases the stimulation thresholds of action potentials in rat neocortical neurones,
whereas baclofen consistently increased this threshold. In addition, baclofen in-
creased, rather than decreased, the threshold stimulation intensity required to
produce action potential bursts evoked in the presence of bicuculline (cf. Ault &
Nadler, 1983; Brady & Swann, 1984). The concentrations of bicuculline that we used,
however, produced apparently complete blockades of f-i.p.s.p.s and any further
depression of these i.p.s.p.s by baclofen was probably precluded.
Although the resistance of the effects of baclofen to antagonism by bicuculline
indicates that the effects of this GABA derivative are not secondary to GABAA
receptor activation, we have no evidence that the actions of baclofen we observed
are mediated by GABAB receptors. Thus, in the presence of bicuculline, we have never
seen baclofen-like hyperpolarizations in response to ionophoretic applications of
GABA. This is in contrast to results obtained in the hippocampus where GABA
produces hyperpolarizations similar to baclofen when GABAA receptors are blocked
with bicuculline (Newberry & Nicoll, 1985). These bicuculline-resistant hyperpolar-
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izations are observed, however, when GABA is applied to the dendritic field of
hippocampal neurones. In our experiments, GABA applications were made from
ionophoretic electrodes that were placed as close to the recording electrode as
possible, and therefore we have presumably applied GABA only near the soma of
neocortical neurones.
The relation between hyperpolarizations and conductance increases produced by baclofen
and baclofen's depressions of stimulation-evoked post-synaptic potentials
The following experimental findings indicate that, although the action of baclofen
to increase post-synaptic potassium conductance certainly contributes to baclofen's
depression of stimulation-evoked post-synaptic potentials, this action alone cannot
account for the depressions of these potentials that were produced by baclofen. First,
the effects could be dissociated. For several neurones, post-synaptic potentials were
markedly reduced by baclofen, but changes in RN were not detected. Conversely, in
a few neurones baclofen produced hyperpolarizations and typical decreases in RN,
but the reductions of post-synaptic potentials were considerably less than those
commonly observed. Secondly, whereas for the majority of neurones baclofen both
decreased post-synaptic potentials and produced hyperpolarizations and detectable
decreases in RN, baclofen applications that produced 70-100 O depressions of
post-synaptic potentials, typically produced only 20-30 O decreases in RN. Thirdly,
in virtually every neurone tested, baclofen's depression of post-synaptic potentials
persisted at times when baclofen-induced decreases in RN were no longer detectable.
Post-synaptic potentials were often still significantly reduced several minutes after
Em and RN had returned to control values. All of these results suggest that, in
addition to reducing the amplitude of synaptically evoked e.p.s.p.s and i.p.s.p.s by
decreasing the resistance of the membrane over which the currents that generate
those post-synaptic potentials flow, baclofen must also reduce the amplitude of
stimulation-evoked post-synaptic currents (e.p.s.c.s and i.p.s.c.s).
For both f- and l-i.p.s.p.s, this is verified by our findings that the conductance
increases associated with each type of i.p.s.p.s were decreased by baclofen. Baclofen's
depressions of i.p.s.p.s were independent ofEm and were not accompanied by changes
in the reversal potential of either f-i.p.s.p.s or l-i.p.s.p.s. Thus baclofen does not reduce
the driving force for the generation of either type of i.p.s.p., but reduces the
magnitude of the conductance increases that precede them.
Although we did not perform Ee.p.s.p determinations, baclofen's reductions of
e.p.s.p. amplitudes were independent of Em over the range of values+ 25 mV from
resting Em. Thus, it is suggested that baclofen does not alter the driving force for
e.p.s.c.s, but reduces the conductance increases that lead to e.p.s.p. generation. We
have not attempted to measure conductance increases during e.p.s.p.s, however, nor
to record e.p.s.c.s under conditions of somatic voltage clamp. As such, the suggestion
that baclofen must reduce e.p.s.c.s rests primarily on the above-stated results which
indicate that the decreases of RN that were measured during baclofen were not of
sufficient magnitude or duration to account for baclofen's reductions of e.p.s.p.
amplitudes.
This conclusion is only valid on the condition that we detected close to the full
extent of the conductance increases produced by baclofen. This condition would not
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be met if baclofen increases membrane conductance selectively at regions of the
neurone that are electronically remote from the site of the recording electrode. If,
in addition, e.p.s.p.s are generated at these same electrotonically remote regions, then
it is conceivable that baclofen could selectively shunt e.p.s.p.s.
That typical decreases in RN were measured during baclofen applications that
produced quite modest reductions of post-synaptic potentials suggests this is not the
case, but this was only observed in a few neurones. The large disparities, however,
between the magnitude and duration of baclofen's reductions of e.p.s.p.s and its
reductions of depolarizations produced by L-glutamate, L-aspartate or NMDA, also
argue against such a hypothetical situation. Like stimulation-evoked e.p.s.p.s and
unlike stimulation-evoked f-i.p.s.p.s or responses to ionophoretically applied GABA,
depolarizations produced by these excitatory amino acids are influenced significantly
by the non-linearities in the current-voltage relations of rat neocortical neurones.
Depolarizations produced by these excitatory amino acids are often accompanied by
apparent increases in RN as a result of the inward rectification displayed by these
neurones at Em values negative to -60 mV. Even when rectification is accounted
for, the decreases in resistance during large (20-30 mV) subthreshold depolarizations
produced by these substances are small.
These results suggest that depolarizations produced by these excitatory amino
acids are generated at sites that are electrotonically remote from the recording
electrode, and yet baclofen's effects on these depolarizations were quantitatively
similar in magnitude and duration to its effects on depolarizations produced by direct
intracellular current injections. It therefore seems unlikely to us that baclofen
depresses e.p.s.p.s by selectively increasing membrane conductance at their electro-
tonically remote sites of generation. Our results do not directly exclude this
possibility however.
Mechanism of baclofen's reduction of stimulation-evoked post-synaptic conductances
On the basis either of direct measurements during i.p.s.p.s, or from the indirect
evidence just described for e.p.s.p.s, our results indicate that baclofen reduces the
magnitude of the conductance increases that precede each post-synaptic potential.
Because baclofen did not reduce either currents or conductance increases evoked by
the direct ionophoretic application of GABA, a post-synaptic blockade by baclofen
of the f-i.p.s.p. conductance is extremely unlikely. Scholfield (1983) also found no
action of baclofen on conductance increases produced by the direct application of
GABA or the GABAA agonist muscimol. Experiments in our laboratory with
excitatory amino acid antagonists indicate that excitatory amino acids contribute
significantly to the generation of e.p.s.p.s in our preparation (unpublished results).
As such, our findings that baclofen did not significantly reduce depolarizations
produced by L-glutamate, L-aspartate, or NMDA and that it did not reduce
L-glutamate-evoked inward current suggest that baclofen does not act post-
synaptically to reduce the conductance increases that generate e.p.s.p.s. Our results
therefore suggest that baclofen reduces the available amount of the synaptically
released transmitters that generate the f-i.p.s.p.s and e.p.s.p.s we record from rat
neocortical neurones.
Indeed, baclofen has been shown to decrease the evoked release of several
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neurotransmitters (Bowery et al. 1980; Olpe et al. 1982; Schlicker, Classen & G6thert,
1984), and importantly to reduce the release of excitatory amino acids in preparations
of the mammalian neocortex (Potashner, 1979; Johnston, Hailstone & Freeman,
1980). Baclofen does not, however, reduce the release ofGABA evoked by potassium
depolarizations or electrical field stimulation from slices of the rat or guinea-pig
neocortex (Potashner, 1979; Johnston et al. 1980).
In the olfactory cortex slice, Collins et al. (1982) also found that baclofen did not
reduce potassium-evoked GABA release. Baclofen did, however, significantly reduce
GABA release evoked by electrical stimulation of the lateral olfactory tract. They
proposed that baclofen's reductions of this type of evoked GABA release, and also
baclofen's apparent reductions of GABAergic post-synaptic inhibition, were
secondary to its direct action to reduce excitatory amino acid neurotransmitter
release and consequently the excitatory drive to GABA-releasing interneurones (see
also Scholfield, 1983). A similar dependence of the activity of the GABAergic
neurones that generate f-i.p.s.p.s in the rat neocortex on stimulation-evoked
excitatory synaptic transmission would both explain our findings and be consistent
with baclofen's lack of effect on directly evoked GABA release.
As mentioned,l-i.p.s.p.s are very similar to the so-called slow i.p.s.p.s evoked in
hippocampal CAI neurones. Because of the similarities between slow i.p.s.p.s and
hyperpolarizations produced by baclofen, it was proposed that both may be
secondary to activation of GABAB receptors (Newberry & Nicoll, 1984, 1985). If
baclofen and the endogenous transmitter that generates l-i.p.s.p.s act on the same
population of post-synaptic receptors or increase the same post-synaptic potassium
conductance, then baclofen and the endogenous transmitter may compete for these
receptors, or the conductance may already be fully activated in the presence of
baclofen, and baclofen's reductions ofl-i.p.s.p.s might at least in part be the result
of its post-synaptic action. At present, this possibility cannot be tested directly
because of the lack of established antagonists of either baclofen-induced hyper-
polarizations or ofl-i.p.s.p.s.
Dunlap (1981) showed that baclofen reduces the duration of the calcium component
of action potentials recorded from dorsal root ganglion neurones in culture. Baclofen
also reduces the duration of the calcium component of action potentials recorded from
neurones in the myenteric plexus (Cherubini & North, 1984), and several authors have
proposed that baclofen reduces neurotransmitter release by reducing inward calcium
currents in presynaptic terminals. Although the results of Shapovalov & Shiriaev(1982) in the frog motoneurone are consistent with such a mechanism, Barry (1984)
concluded that baclofen's presynaptic depression of excitatory transmission at the
crayfish neuromuscular junction was unlikely to be due to a reduction of presynaptic
calcium influx. Consistent reductions in the presynaptic component of stimulation-
evoked calcium entry in the rat hippocampus were only observed at a baclofen
concentration of 50 /SM (Heinemann, Hamon & Konnerth, 1984).
Baclofen had no significant effect, even at very high concentrations, on the
duration of the calcium component of action potentials we recorded from rat
neocortical neurones. Giihwiler & Brown (1985) found that baclofen had no effect on
inward calcium currents recorded from cultured hippocampal neurones under
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voltage-clamp conditions. Although neither our results nor those of Giihwiler and
Brown argue against an effect of baclofen on calcium currents that occur in
presynaptic terminals, they do indicate that baclofen's reduction of somatic calcium
currents in dorsal root ganglion or myenteric plexus neurones do not necessarily
extrapolate to C.N.S. neurones.
Davidoff & Sears (1974) proposed that baclofen's depressions of synaptic trans-
mission might result from baclofen's action to hyperpolarize presynaptic terminals and
consequently to reduce their excitability. Direct experimental evidence indicates,
however, that baclofen does not decrease the excitability of presynaptic terminals
to an extent sufficient to decrease the probability of action potential invasion of the
terminal region (Fox et al. 1978; Capek & Esplin, 1982; Shapovalov & Shiriaev,
1982). Giihwiler & Brown (1985) noted, however, that if baclofen increased the
potassium conductance of presynaptic terminals this might indirectly reduce pre-
synaptic calcium influx by reducing the duration of the action potential. In our
experiments, baclofen's depression of post-synaptic potentials usually outlasted the
increases in post-synaptic conductance that were produced by baclofen by several
minutes. Therefore, if baclofen increases the potassium conductance of presynaptic
terminals in the rat neocortex, these conductance increases have different kinetics
than those we have measured.
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